Market Cap
NaN
52 Wk Range
$ - $
Previous Close
$N/A
Open
$N/A
Day Range
N/A - N/A
Volume
N/A
Avg Volume
N/A
Enterprise Value
6.834M
Cash
4.81M
Avg Qtr Burn
-5.449M
Short % of Float
11.22%
Insider Ownership
6.74%
Institutional Own.
8.27%
Qtr Updated
09/30/24
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
ANTHIM® (obiltoxaximab) Details Anthrax | Approved Quarterly sales | |
PTX-35 (TNFRSF25) Details Solid tumor/s, Cancer | Failed Discontinued | |
HS-130 (OX40L) Details Solid tumor/s, Cancer | Failed Discontinued | |
HS-110 (gp96 + CTAs) Details Lung cancer, Non-small cell lung carcinoma, Cancer | Failed Discontinued |